Bile Duct Cancer Market 2018 – Global Trend in Healthcare Industry by Top 10 Players Analysis and Forecasts Till 2023 | Asserts MRFR

Market Research Future published a Premium Research Report on “Global Bile Duct Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Pune, India - April 16, 2018 /MarketersMedia/ —

The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.2% during the forecast period. Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. According to the National Cancer Institute, in 2014, there were an estimated 66,771 people living with liver and intrahepatic bile duct cancer in the United States. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Rates for new liver and intrahepatic bile duct cancer cases have risen by an average 2.7% each year over the last 10 years. Death rates have been estimated to have risen by an average of 2.6% each year over 2005-2014. Such an increase in the prevalence of bile duct cancer has boosted the market. Additionally, rising healthcare expenditures, increasing awareness for the disease and investments in the R&D for treatment procedures is fuelling the market further. However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected to restrain the market during the forecasted period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .

Key Players in the Bile Duct Cancer Market:

Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.

Bile Duct Cancer Market Regional Analysis:

The Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector. Apart from this, increasing number of patients, increasing healthcare expenditure have boosted the growth of the market in the Americas. According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.

Europe is the second largest bile duct cancer market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development drives the European market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Fund, the per capita healthcare expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and reach USD 68.6 by 2015.

On the other hand, the Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Global Bile Duct Cancer Market Segmentation:

The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.

On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.

On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.

On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.

On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4741 .

Major TOC Bile Duct Cancer Market Research Report – Global Forecast Till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….!

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023

Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)

Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)

Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics For Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, By Type 2016

Figure 5 Global Bile Duct Cancer Market Share, By Diagnosis 2016

Figure 6 Global Bile Duct Cancer Market Share, By Treatment 2016

Figure 7 Global Bile Duct Cancer Market Share, By End Users, 2016

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312

Source URL: https://marketersmedia.com/bile-duct-cancer-market-2018-global-trend-in-healthcare-industry-by-top-10-players-analysis-and-forecasts-till-2023-asserts-mrfr/331637

For more information, please visit https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741

Source: MarketersMedia

Release ID: 331637

More News From The Financial Capital

Eastern China coal mine accident kills 2, leaves 18 trapped

Oct 21, 2018

BEIJING — Two people died and 18 were trapped in a coal mine in eastern China on Sunday after a rock burst destroyed part of a mining tunnel, state broadcaster China Central Television reported. The spontaneous fracturing of rock — a kind of earthquake induced by excavation — took place around 11 p.m. Saturday in Shandong province. Part of a water drainage tunnel was destroyed in the burst, said the official Xinhua News Agency, and two people were killed by fractured rocks that fell in the tunnel. More than 300 people were working inside the mine at the time of...

China's growth slows as officials try to reassure investors

Oct 21, 2018

BEIJING — China reported economic growth sank to a post-global crisis low as finance officials launched a media blitz Friday to shore up confidence in its sagging stock market. Growth in the quarter that ended in September slipped to 6.5 percent over a year earlier from the previous quarter's 6.7 percent, official data showed. It was the slowest rate since early 2009. The world's second-largest economy already was cooling before a tariff war between Beijing and President Donald Trump erupted. Beijing tightened controls on lending last year to rein in a debt boom. That has weighed on housing sales and...

China says ex-Internet czar on trial over corruption charges

Oct 21, 2018

BEIJING — China's former internet censor, who once held high-profile meetings with industry leaders such as Apple CEO Tim Cook and Facebook founder Mark Zuckerberg, was standing trial Friday on corruption allegations, state media reported. Lu Wei is accused of accepting 32 million yuan ($4.6 million) in bribes and has admitted to his crimes and expressed remorse, according to state broadcaster CCTV. It said his trial began Friday in the eastern city of Ningbo. China has 700 million people online, but it heavily censors content, especially that of a political nature, along with sites related to gambling, drugs and pornography....

Asian stocks tumble after Wall Street skids, China slows

Oct 21, 2018

BEIJING — Asian stock markets sank Friday after Wall Street declined on losses for tech and industrial stocks and Chinese economic growth slowed. KEEPING SCORE: Tokyo's Nikkei 225 index fell 1.1 percent to 22,411.33 and Seoul's Kospi shed 0.3 percent to 2,141.06. The Shanghai Composite Index was flat at 2,485.99 and Hong Kong's Hang Seng fell 0.3 percent to 25,378.50. Sydney's S&P-ASX 200 shed 0.2 percent to 5,929.50 and benchmarks in New Zealand, Taiwan and Southeast Asia also retreated. WALL STREET: Investors sold technology and internet stocks, industrials, and companies that rely on consumer spending amid worries about economic growth....

China 'regrets' US leaving postal union amid trade dispute

Oct 21, 2018

BEIJING — China on Thursday criticized Washington's decision to leave the United Nations treaty that regulates international postage, amid a worsening trade dispute between the world's top two economies. Foreign Ministry spokesman Lu Kang said the move should not be linked to China, despite arguments that the arrangement especially benefits Chinese manufacturers by making it cheaper to ship packages from Beijing to New York than from one side of the U.S. to the other. "We regret the US decision to withdraw from the Universal Postal Union," Lu told reporters at a daily press briefing. "We will continue working with all...

Sign up now!

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.

Contact us: sales[at]thefinancialcapital.com